PepRank

Larazotide

56%positive6 reports

Also: larazotide acetate · AT-1001 · INN-202

CleanOral

Tight-junction (zonulin) blocker trialled for celiac; very safe, but efficacy failed phase 3.

GGVLVQPG · unmodified (AT-1001) (8 residues)

GGVLVQPG unmodified (AT-1001)

#6 of 61 research peptides · updated
Access
Grey market
Cost / month
≈ €54–140
researchers' estimate; no listing to price
OralFelt in 15–20 min
6 user reports
Glowing 1Positive 3Nothing 2
  • r/covidlonghaulers· · 1 upvotesOriginal ↗

    Helped tremendously with gastritis and GERD for me at least.

    GlowingOral

    long COVID; sourced from an online peptide shop

  • r/covidlonghaulers· · 6 upvotesOriginal ↗

    Did it help? I'd say yes, a bit, but not as much as I'd hoped based on the impetus for the study.

    PositiveMass General MIS-C trial protocol · Oral · 5 weeks

    long COVID with post-meal tachycardia; bought from a supplement vendor; later credits seven non-consecutive weeks plus iliac venoplasty

  • r/covidlonghaulers· · 3 upvotesOriginal ↗

    My Zonulin was slightly elevated and taking Larazotide did nothing for me.

    Nothing

    long COVID with mildly elevated stool zonulin; argues it only helps when zonulin is high

Users report
There are very few user reports (low confidence). A handful of celiac and long-COVID users take it before restaurant meals and feel less bloating. Most threads are people asking where to buy it, and GI doctors often haven't heard of it. There are no negative experience reports, but the base is too small to estimate a 'felt nothing' share.
Best effects
Less bloating after accidental gluten (anecdotal) · gut-barrier support in long COVID / MIS-C (early research)
Downsides
Hard to source; sold as a 'supplement' by a few vendors · efficacy uncertain
Watch
Generic: unregulated supplement-channel product of uncertain identity
Evidence
Human RCTs — Phase 2b positive at 0.5 mg; phase 3 CedLara terminated for futility 2022; adverse events similar to placebo
Typical use
0.5 mg orally ~15-20 min before meals (trial dose 0.5 mg three times daily).
Getting it
No approved product; a few online vendors sell it as a supplement or research peptide of unverified identity.
Stacked with
BPC-157 and KPV: the gut-repair stack long-COVID and leaky-gut users pair it with. · strict gluten-free diet: celiac users take it as insurance against cross-contamination, not as a licence to eat gluten.

User reports 6

  • r/covidlonghaulers· · 1 upvotesOriginal ↗

    Helped tremendously with gastritis and GERD for me at least.

    GlowingOral

    long COVID; sourced from an online peptide shop

  • r/covidlonghaulers· · 6 upvotesOriginal ↗

    Did it help? I'd say yes, a bit, but not as much as I'd hoped based on the impetus for the study.

    PositiveMass General MIS-C trial protocol · Oral · 5 weeks

    long COVID with post-meal tachycardia; bought from a supplement vendor; later credits seven non-consecutive weeks plus iliac venoplasty

  • r/Celiac· · 3 upvotesOriginal ↗

    I take it 20 minutes before I eat meals at restaurants/take out! Also if I plan on eating something I know might cause a stomach ache, like pizza made from gluten-free wheat starch. If I take it early enough I definitely feel like it helps me be less bloated/not get a stomach ache

    Positivetaken 20 minutes before restaurant or takeout meals · Oral

    celiac; uses it as insurance against cross-contamination

  • r/covidlonghaulers· · 1 upvotesOriginal ↗

    I also tried lorazotide and got benefit with this.

    Positive

    long COVID with night-time pain and breathing episodes

  • r/covidlonghaulers· · 3 upvotesOriginal ↗

    My Zonulin was slightly elevated and taking Larazotide did nothing for me.

    Nothing

    long COVID with mildly elevated stool zonulin; argues it only helps when zonulin is high

  • r/covidlonghaulers· · 2 upvotesOriginal ↗

    I thought it may have helped a little bit with GI stuff

    Nothing

    long COVID

Safety

Tier by safety barStrict CleanBalanced CleanEvidence only Clean

Seen harmMechanismData gapSilent harmProduct

Seen harm 0/3
Adverse events matched placebo across RCTs with 465 people on drug, and the 307-patient phase 3 stopped for futility, not safety. Leffler et al. 2015: larazotide phase 2b, n=342 (Gastroenterology) ↗Larazotide meta-analysis: 465 exposed across 4 RCTs (PubMed 34339872) ↗CedLara phase 3 (NCT03569007), terminated 2022 for futility ↗
Mechanism 0/3
A locally acting oral tight-junction regulator with minimal absorption; no pathway to serious harm is known. Leffler et al. 2015: larazotide phase 2b, n=342 (Gastroenterology) ↗
Data gap 1/3
RCTs with several hundred people up to 12 weeks, but never approved and phase 3 safety results were never published. Larazotide meta-analysis: 465 exposed across 4 RCTs (PubMed 34339872) ↗CedLara phase 3 (NCT03569007), terminated 2022 for futility ↗
Silent harm 0/3
No harm signal; GI effects, if any, would be immediate.
Product 2/3
With no approved product, the few sources are online 'supplement' or research vendors whose identity and dose are unverified.
Never if
Pregnancy or breastfeeding (no human reproductive data)

Where to buy 1 in Europe · 1 total

ShopFormPricePer mgTesting
Condor ResearchEU · SKcapsules · 30 mg€140€4.66/mgNo public tests

Studies 3

More in Gut all 6 →

  1. 1KPV KPV (3 residues) Caution Oral / Topical / Injection≈ €31–61 / month58%positive47 reportsAnti-inflammatory alpha-MSH fragment for gut, skin and allergy inflammation; animal data only.
  2. 2Bovine colostrum CautionSupplement Oral≈ €28–56 / month47%positive24 reportsCow's first milk: immunoglobulins, lactoferrin and growth-factor peptides for gut lining and fewer colds.
  3. 3Polaprezinc (zinc L-carnosine) AH (2 residues) ExcludedSupplement Oral≈ €32 / month54%positive25 reportsJapanese ulcer drug sold as a supplement; the go-to oral 'stomach lining' option for gastritis.
  4. 4Plecanatide Excluded Oral≈ €540–650 / month45%positive25 reportsApproved uroguanylin-like GC-C agonist tablet for constipation and IBS-C; linaclotide's sibling.The label warns of severe diarrhoea (0.6-1% in trials, most within the first days) with instructions to stop and rehydrate, and Reddit users describe days of watery diarrhoea leaving them badly dehydrated. Its sibling linaclotide has post-marketing hospitalisations for the same harm. It is obvious and stops when the drug does, so under a doctor it is a reasonable constipation treatment, but it is a real route to serious harm and does not belong on a clean wellness list.
  5. 5Linaclotide Excluded Oral≈ €450 / month45%positive25 reportsApproved gut-only GC-C agonist pill for IBS-C and constipation; works for many, often too well.The label warns of severe diarrhoea (2% in trials), and post-marketing reports describe dehydration with fainting, low blood pressure and low potassium or sodium that needed IV fluids or hospital, plus rare anaphylaxis and angioedema. The harm is obvious at once and stops when the drug does, so under a doctor it is a reasonable IBS-C treatment, but it is a real route to serious harm and does not belong on a clean wellness list.

Sequence beads

Each bead is one amino acid in the peptide's chain, coloured by its side chain: grey for non-polar, cyan for polar, blue for positively charged and fuchsia for negatively charged. Length and mix tell related peptides apart at a glance, from a two-residue dipeptide like carnosine to a 43-residue protein like thymosin beta-4. The colours describe chemistry only and predict neither effect nor safety.

non-polarpolarpositivenegative

Report grades

Every first-hand Reddit or X report is graded on its own, from glowing through positive, mixed, nothing and negative to bad reaction, and the bar shows how those grades split. Posts that look vendor-adjacent stay on the peptide's page but are left out of the counts.

GlowingPositiveMixedNothingNegativeBad reaction

% positive

The share of a peptide's graded Reddit and X reports that are glowing or positive, vendor-adjacent posts left out. A peptide with few reports is pulled toward the average of all reports, as if it had eight average ones besides its own, so two glowing posts cannot top the list. Kept peptides rank by the same reports' mean grade, shrunk the same way, and excluded ones follow in that order.

Researcher estimate

No first-hand report of this peptide has been graded yet, so the figure is the researchers' own rating out of 10 from what they read about it. It ranks alongside the computed scores until reports arrive.

Safety tier

Each peptide is tiered clean, caution or excluded from its five risk axes under the chosen safety bar. An excluded peptide has a plausible route to serious harm, so it stays listed with the reason but ranks behind every other entry, however good its reviews.

Safety bar

The safety bar sets how much risk it takes to exclude a peptide. Strict: out on any serious mechanism with little human data, or any documented serious harm. Balanced: out on documented serious harm (unless it is obvious, reversible and from a regulated product), or a serious mechanism whose harm would be silent with no human data at all. Evidence only: out only on documented serious harm in humans that is lasting, delayed or from grey-market product.

Seen harm

Documented serious adverse events in humans, from 0 for none despite real exposure to 3 for deaths or several well-documented serious harms. Serious means a hospital or emergency visit or harm lasting weeks, so a headache or a bad night does not count.

Mechanism

A plausible biological route to serious harm at the doses people use, such as growth-factor signalling, hormone-axis suppression, heart or blood-pressure effects or immune activation. It runs from 0 when none is known to 3 when a dangerous pathway has been shown in living animals.

Data gap

How little human safety data exists for the molecule actually sold, from 0 for an approved drug with large trials and years of use to 3 for no human safety data at all. A modified analogue does not inherit its parent's trials.

Silent harm

Whether the feared harm would show quickly or stay hidden, from 0 when it is obvious and goes on stopping to 3 when it is silent and delayed, like tumour promotion or slow organ damage. User reports cannot reveal a harm that takes years to appear, so a high score here limits what good reviews can tell you.

Product

The risk of what people actually buy, from 0 for a regulated pharmacy or supplement product taken by mouth or on the skin to 3 for a grey-market injectable. In one dataset of 6,441 grey-market samples, 42–71% failed basic quality criteria and 15% carried endotoxin.

Evidence

The strongest kind of study behind the peptide's effects, from an approved drug through human controlled trials and small human studies to animal work or nothing of its own. Animal results often fail to carry over to people.

Access

How people get it: as an approved drug, a compounded prescription, an over-the-counter supplement or from the grey market, where nobody checks the vial. The channel decides both the legal position and the risk of a bad batch.

Price per month

Thirty days of the typical dose, from its low end to its high end, priced at the listing a careful buyer would choose: in stock, from a shop scoring 4 of 5 on trust (third-party tested where no score is set), failing that 3, a pure pack before a blend, a European shop first, then the cheapest per mg. The range is the dose's, not the shops'. A per-dose amount counts once a day unless the dose says otherwise. Prices are in euros at ECB rates of 2026-10-29, before shipping; the shop table keeps each listing's price per mg, per gram for bulk supplements. Where no listing can be priced the researchers' own estimate stands in, and says so.

Dose users report

The middle half of the daily doses stated in at least five first-hand reports, vendor posts left out. Where its middle sits more than twice above or below the declared dose, the month is priced at it as well, since what people take is what they pay for.

Testing

Whether the shop publishes lab results: third-party tested means an independent lab checks each batch, own COA means the shop's own certificate of analysis, and no public tests means neither. A certificate shows purity, not safety.

Added peptide

Some packs sold under one peptide's name hold a second one, such as 5 mg GHK-Cu in a nasal kit, stated only in the description. Sprayed in the nose or injected it reaches the blood like an injection, so it carries the risk of that route and is tiered as the injectable form, whatever its tier on the skin. A pack whose page gives no contents list may hold more than its name.